InvestorsHub Logo
icon url

gryfus

10/18/07 12:32 PM

#3156 RE: lordwinmore #3155

Nope, you are very wrong. You cannot use your stem cells when you are sick, and you absolutely cannot use stem cells from your relatives, they are not a perfect cells match. That's not the same thing, and I don't know where you read this.

Do you know that in Europe there are already services for adult stem cells banking and for example many famous sports men are already banking their stem cells?

CLBE didn't get any revenues from stem cells for the simple fact that they have still not started their banking services despite what they told last year. They are one year late and they are starting stem cells banking this month.

Moreover you should also look at neostem (on the amex), which is in the same field, with just a much worse balance sheet and much more debts than clbe, but with a market cap which is 12 times bigger than CLBE just because they are putting out more prs to tease investors.
icon url

Mikelongstock

10/19/07 10:01 AM

#3161 RE: lordwinmore #3155

AUB tests stem-cell therapy on patients
By The Daily Star

Friday, October 19, 2007

BEIRUT: Scientists at the American University of Beirut (AUB) began a pioneering clinical trial earlier this month to test bone-marrow stem-cell therapy on up to six individuals suffering from advanced Multiple Sclerosis (MS), a neurological disease with potentially debilitating effects.

The trial is among the first being carried out in the world, as part of an international task force created about a year ago, following successful animal trials. AUB professor and neuroscientist Bassem Yamout, who is also a member of the European Charcot Foundation Expert Group on the use of human stem cells for treatment of Multiple Sclerosis, is leading the AUB trial which was launched on October 3. AUB assistant dean for research Ali Bazarbachi and his team will be collaborating with Yamout on this experiment.

http://www.dailystar.com.lb/article.asp?edition_id=1&categ_id=1&article_id=86081